| Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer SJ Antonia, A Villegas, D Daniel, D Vicente, S Murakami, R Hui, T Yokoi, ... New England Journal of Medicine 377 (20), 1919-1929, 2017 | 4008 | 2017 |
| Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC SJ Antonia, A Villegas, D Daniel, D Vicente, S Murakami, R Hui, T Kurata, ... New England Journal of Medicine 379 (24), 2342-2350, 2018 | 2603 | 2018 |
| mTOR: a pharmacologic target for autophagy regulation YC Kim, KL Guan The Journal of clinical investigation 125 (1), 25-32, 2015 | 1742 | 2015 |
| Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy J Kim, YC Kim, C Fang, RC Russell, JH Kim, W Fan, R Liu, Q Zhong, ... Cell 152 (1), 290-303, 2013 | 851 | 2013 |
| Nivolumab in resected and unresectable metastatic melanoma: characteristics of immune-related adverse events and association with outcomes M Freeman-Keller, Y Kim, H Cronin, A Richards, G Gibney, JS Weber Clinical Cancer Research 22 (4), 886-894, 2016 | 832 | 2016 |
| Differential regulation of mTORC1 by leucine and glutamine JL Jewell, YC Kim, RC Russell, FX Yu, HW Park, SW Plouffe, ... Science 347 (6218), 194-198, 2015 | 717 | 2015 |
| Alternative Wnt signaling activates YAP/TAZ HW Park, YC Kim, BO Yu, T Moroishi, JS Mo, SW Plouffe, Z Meng, KC Lin, ... Cell 162 (4), 780-794, 2015 | 659 | 2015 |
| Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations PK Paik, E Felip, R Veillon, H Sakai, AB Cortot, MC Garassino, J Mazieres, ... New England Journal of Medicine 383 (10), 931-943, 2020 | 647 | 2020 |
| Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study MC Garassino, BC Cho, JH Kim, J Mazières, J Vansteenkiste, H Lena, ... The Lancet Oncology 19 (4), 521-536, 2018 | 541 | 2018 |
| Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway JS Mo, Z Meng, YC Kim, HW Park, CG Hansen, S Kim, DS Lim, KL Guan Nature cell biology 17 (4), 500-510, 2015 | 539 | 2015 |
| Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation YE Chung, MJ Kim, YN Park, JY Choi, JY Pyo, YC Kim, HJ Cho, KA Kim, ... Radiographics 29 (3), 683-700, 2009 | 520 | 2009 |
| Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP FX Yu, J Luo, JS Mo, G Liu, YC Kim, Z Meng, L Zhao, G Peyman, ... Cancer cell 25 (6), 822-830, 2014 | 472 | 2014 |
| Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat SM Lee, TY Yune, SJ Kim, DW Park, YK Lee, YC Kim, YJ Oh, ... Journal of neurotrauma 20 (10), 1017-1027, 2003 | 363 | 2003 |
| Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy JS Ryu, YC Hong, HS Han, JE Lee, S Kim, YM Park, YC Kim, TS Hwang Lung cancer 44 (3), 311-316, 2004 | 352 | 2004 |
| Ginsenosides Rb1and Rg3protect cultured rat cortical cells from glutamate‐induced neurodegeneration YC Kim, SR Kim, GJ Markelonis, TH Oh Journal of neuroscience research 53 (4), 426-432, 1998 | 337 | 1998 |
| Sestrins inhibit mTORC1 kinase activation through the GATOR complex A Parmigiani, A Nourbakhsh, B Ding, W Wang, YC Kim, K Akopiants, ... Cell reports 9 (4), 1281-1291, 2014 | 336 | 2014 |
| Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia Q Lan, CA Hsiung, K Matsuo, YC Hong, A Seow, Z Wang, HD Hosgood III, ... Nature genetics 44 (12), 1330-1335, 2012 | 326 | 2012 |
| Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury TY Yune, JY Lee, GY Jung, SJ Kim, MH Jiang, YC Kim, YJ Oh, ... Journal of Neuroscience 27 (29), 7751-7761, 2007 | 306 | 2007 |
| Highly aligned ultrahigh density arrays of conducting polymer nanorods using block copolymer templates JI Lee, SH Cho, SM Park, JK Kim, JK Kim, JW Yu, YC Kim, TP Russell Nano letters 8 (8), 2315-2320, 2008 | 270 | 2008 |
| Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy KA Ahmed, DG Stallworth, Y Kim, PAS Johnstone, LB Harrison, ... Annals of Oncology 27 (3), 434-441, 2016 | 256 | 2016 |
